Evaluation of effectiveness and safety of Etanercept in children with Juvenile psoriatic arthritis
Introduction. Juvenile psoriatic arthritis is a chronic inflammatory disease accounting for 3-10% of all juvenile arthritis. Genetically engineered biological medications, particularly Etanercept, proved to be effective and safe in the adult patients with psoriatic arthritis; however, there are only...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ltd. “The National Academy of Pediatric Science and Innovation”
2020-09-01
|
| Series: | Rossijskij Vestnik Perinatologii i Pediatrii |
| Subjects: | |
| Online Access: | https://www.ped-perinatology.ru/jour/article/view/1209 |